Condition: Melanoma · Sponsor: Regeneron Pharmaceuticals
This study is researching an experimental drug called fianlimab (also known as REGN3767), combined with another medication called cemiplimab (also known as REGN2810), called "study drugs". The study is focused on patients with a type of skin cancer known as melanoma. The aim of the study is to see how safe and effective the combination of fianlimab and cemiplimab is in treating melanoma, in comparison with the combination of two medications, relatlimab and nivolumab, commercialized under the brand name Opdualag™ and approved for the treatment of melanoma in adults and children. The study is looking at several other research questions, including: * What side effects may happen from taking the study drugs. * How much study drug is in the blood at different times. * Whether the body makes antibodies against the study drugs (which could make the drug less effective or could lead to side effects)
This description comes directly from the study's public registry record.
Clinical Trials Administrator · 844-734-6643 · clinicaltrials@regeneron.com
Always discuss trial participation with your own doctor first.
| Ironwood Cancer & Research Centers | Chandler, Arizona, United States | Recruiting |
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | Recruiting |
| Arizona Oncology Associates | Tucson, Arizona, United States | Withdrawn |
| University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | Recruiting |
| Providence Medical Foundation | Fullerton, California, United States | Recruiting |
| Cancer and Blood Specialty Clinic | Los Alamitos, California, United States | Recruiting |
| University of California Los Angeles | Los Angeles, California, United States | Recruiting |
| St. Joseph Hospital Orange | Orange, California, United States | Recruiting |
| University of California Irvine, UCI Medical Center | Orange, California, United States | Recruiting |
| Eisenhower Medical Center | Rancho Mirage, California, United States | Withdrawn |
| Emad Ibrahim, MD, Inc. | Redlands, California, United States | Recruiting |
| Sutter Health | Sacramento, California, United States | Recruiting |
+ 98 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06246916